Efficacy of niraparib by timing of surgery and residual disease: A post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study Meeting Abstract
| Authors: | O'Cearbhaill, R.; Grabowski, J.; Pérez-Fidalgo, J. A.; Monk, B. J.; Tusquets, I.; Mccormick, C.; Pradera, J. F.; Moore, R. G.; Vulsteke, C.; Shahin, M.; Forget, F.; Bradley, W. H.; Hietanen, S.; O'Malley, D.; Dørumn, A.; Slomovitz, B. M.; Baumann, K.; Selle, F.; Calvert, P. M.; Artioli, G.; Levy, T.; Kumar, A.; Malinowska, I.; Li, Y.; Gupta, D.; González-Martín, A. |
| Abstract Title: | Efficacy of niraparib by timing of surgery and residual disease: A post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study |
| Meeting Title: | 2022 Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 45 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Nov 13-16 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2022-11-01 |
| Start Page: | 120 |
| End Page: | 121 |
| Language: | English |
| ACCESSION: | WOS:000883051700284 |
| PROVIDER: | wos |
| DOI: | 10.1159/000521004 |
| Notes: | Meeting Abstract: 674 -- Source: Wos |
